Camden Capital, LLC Amarin Corp Plcuk Transaction History
Camden Capital, LLC
- $1.14 Billion
- Q1 2024
Shares
3 transactions
Others Institutions Holding AMRN
# of Institutions
184Shares Held
87.9MCall Options Held
528KPut Options Held
219K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$17.1 Million3.87% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12MShares$8.3 Million1.12% of portfolio
-
Dg Capital Management, LLC New York, NY6.44MShares$4.45 Million3.54% of portfolio
-
Eversept Partners, LP New York, NY6.21MShares$4.29 Million0.42% of portfolio
-
Morgan Stanley New York, NY3.61MShares$2.49 Million0.0% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $278M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...